{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "China is facing international pressure to prove that its food exports are safe, weeks after a tainted pet food case.", "headline": {"main": "An Export Boom Suddenly Facing a Quality Crisis", "sub": "Customers Worldwide Pressing Beijing to Act After Tainted-Food Case ;", "print_headline": "An Export Boom Suddenly Facing A Quality Crisis"}, "abstract": null, "print_page": "1", "word_count": "1601", "_id": "548a43fe7988102fcc130453", "snippet": "China is facing international pressure to prove that its food exports are safe, weeks after a tainted pet food case.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2007/05/18/business/worldbusiness/18trade.html", "multimedia": [{"subtype": "xlarge", "url": "images/2007/05/18/business/18trade.600.jpg", "height": 300, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2007/05/18/business/18trade.600.jpg", "xlargeheight": "300"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2007/05/18/business/18trade.75.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2007/05/18/business/18trade.75.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": "World Business", "keywords": [{"value": "Pet Foods", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Food Contamination and Poisoning", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "China", "is_major": "N", "rank": "3", "name": "glocations"}, {"value": "International Trade and World Market", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Food", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Accidents and Safety", "is_major": "N", "rank": "6", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "David", "lastname": "BARBOZA"}], "original": "By DAVID BARBOZA"}, "document_type": "article", "pub_date": "2007-05-18T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Medicare proposed to sharply curtail reimbursement for Amgen\u2019s biggest selling product, the anemia drug Aranesp.", "headline": {"main": "Shares of Anemia Drug Makers Slide as Medicare Threatens to Cut Reimbursement", "print_headline": "Shares of Anemia Drug Makers Slide as Medicare Threatens to Cut Reimbursement"}, "abstract": null, "print_page": "3", "word_count": "699", "_id": "548a269b7988102fcc130194", "snippet": "Medicare proposed to sharply curtail reimbursement for Amgen\u2019s biggest selling product, the anemia drug Aranesp.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2007/05/16/business/16amgen.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Amgen Inc", "is_major": "N", "rank": "1", "name": "organizations"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Medicare", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Health Insurance and Managed Care", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Anemia", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "6", "name": "subject"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2007-05-16T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "News", "blog": [], "news_desk": "Dining", "lead_paragraph": "The recent food-safety scares have prompted calls to revamp the Food and Drug Administration. ", "headline": {"main": "Who\u2019s Watching What We Eat?", "print_headline": "Who\u2019s Watching What We Eat?"}, "abstract": null, "print_page": "1", "word_count": "1770", "_id": "548a23837988102fcc130144", "snippet": "The recent food-safety scares have prompted calls to revamp the Food and Drug Administration.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2007/05/16/dining/16fda.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Food Contamination and Poisoning", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Law and Legislation", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "3", "name": "organizations"}, {"value": "Senate", "is_major": "N", "rank": "4", "name": "organizations"}, {"value": "House of Representatives", "is_major": "N", "rank": "5", "name": "organizations"}, {"value": "Health and Human Services Department", "is_major": "N", "rank": "6", "name": "organizations"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Marian", "lastname": "BURROS"}], "original": "By MARIAN BURROS"}, "document_type": "article", "pub_date": "2007-05-16T00:00:00Z", "section_name": "Food"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Amgen shares were battered again yesterday after Medicare proposed to sharply curtail reimbursement for the company's biggest selling product, the anemia drug Aranesp. Some analysts said the proposed restrictions, announced late Monday, could cut use of the drug by as much as half. But the Medicare effort is likely to face opposition from some doctors and patient groups, who say such drugs help cancer patients cope with chemotherapy.", "headline": {"main": "Shares of Anemia Drug Makers Slide as Medicare Threatens to Cut Reimbursement"}, "abstract": "Amgen shares are battered after Medicare proposes to sharply curtail reimbursement for company's biggest selling product, anemia drug Aranesp; some analysts say proposed restrictions could cut use of drug by as much as half; Medicare effort is likely to face opposition from some doctors and patient groups, who say such drugs help cancer patients cope with chemotherapy; proposals, which would also apply to Johnson & Johnson's anemia drug Procrit follow recent reports suggesting that drugs, widely used to treat anemia in cancer patients, could actually be making tumors worse or hastening deaths; Food and Drug Administration advisory committee last week recommended restrictions on use of drugs (M)", "print_page": "3", "word_count": 699, "_id": "4fd25d078eb7c8105d80b008", "snippet": "Amgen shares were battered again yesterday after Medicare proposed to sharply curtail reimbursement for the company's biggest selling product, the anemia drug Aranesp.     Some analysts said the proposed restrictions, announced late Monday, could cut...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9400E5D91331F935A25756C0A9619C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "JOHNSON & JOHNSON INC"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "organizations", "value": "AMGEN INC"}, {"name": "subject", "value": "HEALTH INSURANCE AND MANAGED CARE"}, {"name": "subject", "value": "PROCRIT (DRUG)"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ARANESP (DRUG)"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "CHEMOTHERAPY"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "ANEMIA"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Andrew", "rank": 1, "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2007-05-16T00:00:00Z", "section_name": "Health; Business"}], "meta": {"hits": 4, "offset": 0, "time": 46}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}